Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Vaidya Sane
Quarter-by-quarter operating performance
Financials of Vaidya Sane
Annual income statement trend
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales + | 99 | 99 | 90 | 107 |
| Expenses + | 91 | 95 | 76 | 91 |
| Operating Profit | 9 | 5 | 13 | 15 |
| OPM % | 9% | 5% | 15% | 14% |
| Other Income + | 1 | 2 | 1 | 2 |
| Interest | 1 | 0 | 0 | 1 |
| Depreciation | 3 | 3 | 4 | 6 |
| Profit before tax | 6 | 3 | 10 | 11 |
| Tax % | 25% | 30% | 28% | 17% |
| Net Profit + | 5 | 2 | 7 | 9 |
| EPS in Rs | 4.59 | 1.88 | 6.80 | 8.55 |
| Dividend Payout % | 5% | 0% | 0% | 0% |
Financials of Vaidya Sane
Capital structure and asset base
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 |
| Reserves | 30 | 45 | 52 | 77 |
| Borrowings + | 0 | 2 | 1 | 3 |
| Other Liabilities + | 14 | 12 | 13 | 14 |
| Total Liabilities | 55 | 70 | 77 | 105 |
| Fixed Assets + | 21 | 28 | 34 | 35 |
| CWIP | 2 | 2 | 1 | 2 |
| Investments | 15 | 18 | 21 | 40 |
| Other Assets + | 17 | 21 | 20 | 28 |
| Total Assets | 55 | 70 | 77 | 105 |
Financials of Vaidya Sane
Operating, investing and financing cash movement
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 0 | -1 | 11 | 5 |
| Cash from Investing Activity + | 1 | -13 | -10 | -24 |
| Cash from Financing Activity + | -1 | 15 | -1 | 17 |
| Net Cash Flow | -1 | 1 | -0 | -2 |
| Free Cash Flow | -7 | -12 | 2 | -2 |
| CFO/OP | 31% | -9% | 93% | 49% |
Financials of Vaidya Sane
Working capital efficiency and return ratios
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 22 | 22 | 31 | 35 |
| Inventory Days | 58 | 82 | 70 | |
| Days Payable | 101 | 149 | 127 | |
| Cash Conversion Cycle | 22 | -20 | -37 | -21 |
| Working Capital Days | -2 | 5 | 7 | 112 |
| ROCE % | 6% | 18% | 15% |
Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients. Key concall takeaways from QMS…
PAT grew 23.8% y-o-y in Q1 FY27, showing healthy bottom-line growth (Page 4). Key concall takeaways from Laxmi Dental Ltd's Q1 FY27 earnings call — and how it…
Plastic labware market is expanding faster than glass, currently at INR1,200 crores, signaling long-term sector growth opportunities. Key concall takeaways…
Tarsons has undertaken a significant capex of INR 600 crores announced in 2021-22, with partial commercialization in 2026. Key concall takeaways from Tarsons…